Dysregulation of the mitosis-meiosis switch in testicular carcinoma in situ

Journal of Pathology

Volumn 229, Issue 4, 2013, Pages 588-598

  Jørgensen, Anne ^a   Nielsen, John E ^a   Almstrup, Kristian ^a   Toft, Birgitte Grønkær ^a   Petersen, Bodil Laub ^a,b   Meyts, Ewa Rajpert De ^a  

^a Mental Health Center Glostrup   (Denmark)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CIS testis; DMRT1; meiosis signalling; spermatocytic seminoma; testicular germ cell tumours

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 26B; KI 67 ANTIGEN; MELANOMA ANTIGEN 4; MONOCLONAL ANTIBODY D2-40; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN DMC1; PROTEIN DMRT1; PROTEIN NANOS2; PROTEIN NANOS3; PROTEIN PLAP; PROTEIN SCP3; PROTEIN STRA8; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEIOSIS; MITOSIS; PREPUBERTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEMINOMA; SEX DIFFERENTIATION; SIGNAL TRANSDUCTION; TESTIS CARCINOMA;

ADOLESCENT; CARCINOMA IN SITU; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEIOSIS; MITOSIS; NEOPLASMS, GERM CELL AND EMBRYONAL; PUBERTY; SIGNAL TRANSDUCTION; TESTICULAR NEOPLASMS; TESTIS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84874110677     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4154     Document Type: Article

References (54)

1. Skakkebaek NE, Berthelsen JG, Giwercman A, et al,. Carcinoma in situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 1987; 10: 19-28.
2. Oosterhuis JW, Looijenga LH,. Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 2005; 5: 210-222.
3. Almstrup K, Hoei-Hansen CE, Wirkner U, et al,. Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 2004; 64: 4736-4743.
4. Sonne SB, Almstrup K, Dalgaard M, et al,. Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res 2009; 69: 5241-5250.
5. Rajpert-De Meyts E., Developmental model for the pathogenesis of testicular carcinoma in situ: environmental and genetic aspects. Hum Reprod Update 2006; 12: 303-323.
6. Müller J, Skakkebæk NE, Ritzén EM, et al,. Carcinoma in situ of the testis in children with 45,X/46,XY gonadal dysgenesis. J Pediatr 1985; 106: 431-436.
7. Pleskacova J, Hersmus R, Oosterhuis JW, et al,. Tumor risk in disorders of sex development. Sex Dev 2010; 4: 259-269.
8. Cools M, Woffenbuttel KP, Drop SLS, et al,. Gonadal development and tumor formation at the crossroads of male and female sex determination. Sex Dev 2011; 5: 167-180.
9. Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, et al,. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol 2003; 200: 370-374.
10. Skakkebaek NE, Rajpert-De Meyts E, Main KM,. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001; 16: 972-978.
11. Le Bouffant R, Guerquin MJ, Duquenne C, et al,. Meiosis initiation in the human ovary requires intrinsic retinoic acid synthesis. Hum Reprod 2010; 10: 2579-2590.
12. Childs AJ, Cowan G, Kinnell HL, et al,. Retinoic acid signalling and the control of meiotic entry in the human fetal gonad. PLoS One 2011; 6 (6): e20249.
13. Jørgensen A, Nielsen JE, Blomberg Jensen M, et al,. Analysis of meiosis regulators in human gonads: a sexually dimorphic spatio-temporal expression pattern suggests involvement of DMRT1 in meiotic entry. Mol Hum Reprod 2012; 18: 523-534.
14. Kimble J, Page D,. The mysteries of sexual identity: the germ cell's perspective. Science 2007; 316: 400-401.
15. Griswold MD, Hogarth CA, Bowles J, et al,. Initiating meiosis: the case for retinoic acid. Biol Reprod 2012; 86: 1-7.
16. Bowles J, Koopman P,. Precious cargo: regulation of sex-specific germ cell development in mice. Sex Dev 2013; 7: 46-60.
17. Matson CK, Murphy MW, Griswold MD, et al,. The mammalian double sex homolog DMRT1 is a transcriptional gatekeeper that controls the mitosis versus meiosis decision in male germ cells. Dev Cell 2010; 19: 612-624.
18. Krentz AD, Murphy MW, Sarver AL, et al,. DMRT1 promotes oogenesis by transcriptional activation of Stra8 in the mammalian fetal ovary. Dev Biol 2011; 356: 63-70.
19. Krentz AD, Murphy MW, Kim S, et al,. The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency. Proc Natl Acad Sci USA 2009; 106: 22323-22328.
20. Bennett CP, Docherty Z, Robb SA, et al,. Deletion 9p and sex reversal. J Med Genet 1993; 30: 518-520.
21. Raymond CS, Parker ED, Kettlewell JR, et al,. A region of human chromosome 9p required for testis development contains two genes related to known sexual regulators. Hum Mol Genet 1999; 8: 989-996.
22. Livadas S, Mavrou A, Sofocleous C, et al,. Gonadoblastoma in a patient with del(9)(p22) and sex reversal: report of a case and review of the literature. Cancer Genet Cytogenet 2003; 143: 174-177.
23. Ounap K, Uibo O, Zordania R, et al,. Three patients with 9p deletions including DMRT1 and DMRT2: a girl with XY complement, bilateral ovotestes, and extreme growth retardation, and two XX females with normal pubertal development. Am J Med Genet A 2004; 130A: 415-423.
24. Ledig S, Hiort O, Wünsch L, et al,. Partial deletion of DMRT1 causes 46,XY ovotesticular disorder of sexual development. Eur J Endocrinol 2012; 167: 119-124.
25. Looijenga LHJ, Hersmus R, Gillis AJM, et al,. Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene. Cancer Res 2006; 66: 290-302.
26. Turnbull C, Rapley EA, Seal S, et al,. UK Testicular Cancer Collaboration. Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat Genet 2010; 42: 604-607.
27. Kanetsky PA, Mitra N, Vardhanabhuti S, et al,. A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility. Hum Mol Genet 2011; 20: 3109-3117.
28. Kratz CP, Han SS, Rosenberg PS, et al,. Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour. J Med Genet 2011; 48: 473-476.
29. Poynter JN, Hooten AJ, Frazier AL, et al,. Associations between variants in KITLG, SPRY4, BAK1, and DMRT1 and pediatric germ cell tumors. Genes Chromosomes Cancer 2012; 51: 266-271.
30. Lim J, Goriely A, Turner GD, et al,. OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia. J Pathol 2011; 224: 473-483.
31. Blomberg Jensen M, Jørgensen A, Nielsen JE, et al,. Vitamin D metabolism and effects on pluripotency genes and cell differentiation in testicular germ cell tumors in vitro and in vivo. Neoplasia 2012; 14: 952-963.
32. Jørgensen A, Blomberg Jensen M, Nielsen JE, et al,. Influence of vitamin D on cisplatin sensitivity in testicular germ cell cancer-derived cell lines and in a NTera2 xenograft model. J Steroid Metab Mol Biol 2013; doi: 10.1016/jsbmb.2012.10.008.
33. Blomberg Jensen M, Nielsen JE, Jørgensen A, et al,. Vitamin D receptor and vitamin D-metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod 2010; 25: 1303-1311.
34. Sonne SB, Herlihy AS, Hoei-Hansen CE, et al,. Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours. Virchows Arch 2006; 449: 200-206.
35. Almstrup K, Nielsen JE, Mlynarska O, et al,. Carcinoma in situ testis displays permissive chromatin modifications similar to immature foetal germ cells. Br J Cancer 2010; 103: 1269-1276.
36. von Kopylow K, Staege H, Spiess AN, et al,. Differential marker protein expression specifies rarefaction zone-containing human Adark spermatogonia. Reproduction 2012; 143: 45-57.
37. Rajpert-De Meyts E, Kvist M, Skakkebaek NE,. Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance. Virchows Arch 1996; 1428: 133-139.
38. Gueler B, Sonne SB, Zimmer J, et al,. AZFa protein DDX3Y is differentially expressed in human male germ cells during development and in testicular tumours: new evidence for phenotypic plasticity of germ cells. Hum Reprod 2012; 27: 1547-1555.
39. Matson CK, Murphy MW, Sarver AL, et al,. DMRT1 prevents female reprogramming in the postnatal mammalian testis. Nature 2011; 476: 101-104.
40. Matson CK, Zarkower D,. Sex and the singular DM domain: insights into sexual regulation, evolution and plasticity. Nat Rev Genet 2012; 13: 163-174.
41. Bush JM, Gardiner DW, Palmer JS, et al,. Testicular germ cell tumours in dogs are predominantly of spermatocytic seminoma type and are frequently associated with somatic cell tumours. Int J Androl 2011; 34: e288-295.
42. Lindhardt Johansen M, Hagen CP, Rajpert-De Meyts E, et al,. 45,X/46,XY mosaicism: Phenotypic characteristics, growth and reproductive function-a retrospective longitudinal study. J Clin Endocrinol Metab 2012; 97 (8): e1540-e1549.
43. Adamah DJ, Gokhale PJ, Eastwood DJ, et al,. Dysfunction of the mitotic:meiotic switch as a potential cause of neoplastic conversion of primordial germ cells. Int J Androl 2006; 29: 219-227.
44. Rajpert-De Meyts E, Hoei-Hansen C,. From gonocytes to testicular cancer: the role of impaired gonadal development. Ann NY Acad Sci 2007; 1120: 168-180.
45. Atkin NB, Baker MC,. Specific chromosome change, i(12p), in testicular tumours? Lancet 1982; 2: 1349.
46. Castedo SM, de Jong B, Oosterhuis JW, et al,. i(12p)-negative testicular germ cell tumors. A different group? Cancer Genet Cytogenet 1998; 35: 171-178.
47. Kraggerud SM, Skotheim RI, Szymanska J, et al,. Genome profiles of familial/bilateral and sporadic testicular germ cell tumors. Genes Chromosomes Cancer 2002; 34: 168-174.
48. Skotheim RI, Monni O, Mousses S, et al,. New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res 2002; 62: 2359-2364.
49. Tedesco M, Farini D, De Felici M,. Impaired meiotic competence in putative primordial germ cells produced from mouse embryonic stem cells. Int J Dev Biol 2011; 55: 215-22.
50. Bowles J, Knight D, Smith C, et al,. Retinoic signalling determines germ cell fate in mice. Science 2006; 312: 596-600.
51. Koubova J, Menke DB, Zhou Q, et al,. Retinoic acid regulates sex-specific timing of meiotic initiation in mice. Proc Natl Acad Sci USA 2006; 103: 2474-2479.
52. Suzuki A, Saga Y,. Nanos2 suppresses meiosis and promotes male germ cell differentiation. Genes Dev 2008; 22: 430-435.
53. Barrios F, Filipponi D, Pellegrini M, et al,. Opposing effects of retinoic acid and FGF9 on Nanos2 expression and meiotic entry of mouse germ cells. J Cell Sci 2010; 123: 871-880.
54. Childs AJ, Kinnell HL, He J, et al,. LIN28 is selectively expressed by primordial and pre-meiotic germ cells in the human fetal ovary. Stem Cells Dev 2012; 21: 2343-2349.